Latest cancer drug News

Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics
Hope becomes reality for Australians with multiple myeloma
Ludwig Lausanne’s Ping-Chih Ho Elected AAAS Fellow
Scientists identify regenerative checkpoint that limits muscle repair
Remote-controlled CAR-T For Safer Immunotherapy
Affordable access to life extending drug for people with incurable breast cancer
Europe’s Cutting-edge Research As Driver Of Innovation
A diet and drug combo could reverse malignancy to treat a pediatric cancer
Hidden role of ‘cell protector’ opens cancer treatment possibilities
Lab-grown tumour models offer new hope for treating childhood brain cancer
Advanced Prostate Cancer Drug Step Closer To Clinic
Enhertu: drug approved for advanced cancers – here’s what you need to know
Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
New Dual Leadership To Advance Technology Transfer
Baylor and Rice receive $2.3 million to develop antibody therapy for metastatic breast cancer
Remote-controlled Car For Cancer Immunotherapy
Cancer drug offers hope for cardiovascular patients: Breakthrough from the Centre for PAD
Life prolonging breast cancer drug receives expanded access on the PBS
New Discoveries Reveal That TRP14 (TXNDC17) Is A Crucial Enzyme for Cysteine Metabolism and Disease Resistance
Step Forward On Cancer Drug Funding But More To Do
Life prolonging breast cancer drug recommended for PBS subsidy, but it is not time to celebrate
Life prolonging breast cancer drug recommended for PBS subsidy, but it is not time to celebrate
Researchers reveal mechanism of drug reactivating tumor suppressors
Innovative modelling may help breast cancer patients who don’t respond to treatment
How a timekeeping gene affects tumor growth depends entirely on context
Humanitarian Michael Crossland is Armidale’s next Australia Day Ambassador
QIMR Berghofer engages AI partner to fast-track cancer drug discovery
EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic
Independent watchdog essential to combat research misconduct
Drug screen points toward novel diabetes treatments
New target to beat cancer drug resistance
New antibiotics on way – but not quickly enough
$40k cost saving: New prostate cancer drug listed on PBS
Maths unlocks molecular interactions that open window to how life evolved
We asked ChatGPT and Dr Google the same questions about cancer. Here’s what they said
In search of inflammatory Achilles heel
Differences in animal biology can affect cancer drug development
Eliminating partners of cancer
Precision medicine trial opens for rare adult and paedatric cancers
New approach to treatment of deadly kidney cancer
Collaboration to jumpstart research
Unique insight into inner workings of our cellular powerplants
New clinical trial to test cancer drug in motor neuron disease
Tumor release of lactate forces nearby cells into supportive role
Cell division finding could lead to new cancer treatments
Filling gaps in immune system cancer research
Ludwig Cancer Research scientists to present advances in cancer immunotherapy, metastasis
New cancer drug formulations to be tested in Wollongong labs